Perk Labs Inc.
PERK
CNSX
| 08/31/2023 | 05/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -74.14% | 1,350.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -74.14% | 1,350.00% | |||
| Cost of Revenue | -76.90% | 2,536.36% | |||
| Gross Profit | -- | -100.00% | |||
| SG&A Expenses | -8.66% | 3,196.61% | |||
| Depreciation & Amortization | -92.74% | -29.55% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.81% | 395.94% | |||
| Operating Income | 12.49% | -378.01% | |||
| Income Before Tax | 12.84% | -350.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.84% | -350.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.84% | -350.71% | |||
| EBIT | 12.49% | -378.01% | |||
| EBITDA | 12.49% | -378.06% | |||
| EPS Basic | 15.38% | -160.00% | |||
| Normalized Basic EPS | 12.50% | -166.67% | |||
| EPS Diluted | 15.38% | -160.00% | |||
| Normalized Diluted EPS | 14.29% | -133.33% | |||
| Average Basic Shares Outstanding | 3.62% | 95.37% | |||
| Average Diluted Shares Outstanding | 6.37% | 114.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||